AR006550A1 - Metodo de preparacion de inhibidores de fosfodiesterasa iv - Google Patents

Metodo de preparacion de inhibidores de fosfodiesterasa iv

Info

Publication number
AR006550A1
AR006550A1 ARP970101372A ARP970101372A AR006550A1 AR 006550 A1 AR006550 A1 AR 006550A1 AR P970101372 A ARP970101372 A AR P970101372A AR P970101372 A ARP970101372 A AR P970101372A AR 006550 A1 AR006550 A1 AR 006550A1
Authority
AR
Argentina
Prior art keywords
phosphodiesterase
inhibitors
preparation
phenyl
alkyl
Prior art date
Application number
ARP970101372A
Other languages
English (en)
Spanish (es)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9612083.7A external-priority patent/GB9612083D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of AR006550A1 publication Critical patent/AR006550A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C07D213/34—Sulfur atoms to which a second hetero atom is attached
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ARP970101372A 1996-04-17 1997-04-07 Metodo de preparacion de inhibidores de fosfodiesterasa iv AR006550A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1568796P 1996-04-17 1996-04-17
GBGB9612083.7A GB9612083D0 (en) 1996-06-10 1996-06-10 Method of preparing phosphodiesterase IV inhibitors

Publications (1)

Publication Number Publication Date
AR006550A1 true AR006550A1 (es) 1999-09-08

Family

ID=26309476

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970101372A AR006550A1 (es) 1996-04-17 1997-04-07 Metodo de preparacion de inhibidores de fosfodiesterasa iv

Country Status (10)

Country Link
EP (1) EP0898564A1 (cs)
CN (1) CN1216532A (cs)
AR (1) AR006550A1 (cs)
AU (1) AU2459297A (cs)
BR (1) BR9708684A (cs)
CZ (1) CZ333298A3 (cs)
EA (1) EA000877B1 (cs)
SK (1) SK143198A3 (cs)
TW (1) TW426669B (cs)
WO (1) WO1997038976A1 (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW508353B (en) * 1996-09-17 2002-11-01 Merck & Co Inc Method of preparing phosphodiesterase IV inhibitors
EP0931066B1 (en) * 1996-09-17 2002-05-15 Merck & Co., Inc. Method of preparing phosphodiesterase iv inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW263495B (cs) * 1992-12-23 1995-11-21 Celltech Ltd
GB9326173D0 (en) * 1993-12-22 1994-02-23 Celltech Ltd Chemical compounds and process

Also Published As

Publication number Publication date
WO1997038976A1 (en) 1997-10-23
CN1216532A (zh) 1999-05-12
TW426669B (en) 2001-03-21
EA000877B1 (ru) 2000-06-26
CZ333298A3 (cs) 1999-03-17
SK143198A3 (en) 1999-06-11
AU2459297A (en) 1997-11-07
EA199800931A1 (ru) 1999-04-29
BR9708684A (pt) 1999-08-03
EP0898564A1 (en) 1999-03-03

Similar Documents

Publication Publication Date Title
ATE215078T1 (de) Verbessertes verfahren zum herstellen von geschützten 3,4-dihydroxybuttersäure estern
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
ES2139943T3 (es) Nuevos inhibidores de la sintasa de prostaglandina.
ES2053479T3 (es) Hidrorepelente para albañileria.
ES2056105T3 (es) Di-t-butilfenoles sustituidos.
PT88992A (pt) Processo para a preparacao de compostos contendo fosforo uteis como inibidores de colagenase
ES2045180T3 (es) Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
BR8703169A (pt) Processo para preparacao de(2,2)-paraciclofano e derivados deste
CO5050366A1 (es) Compuesto fungicida correspondiente a compuesto 7-bromo-3- metil-3,4-dihidrotienol[3,2-d]pirimidin-4-ona
ES525358A0 (es) Procedimiento para la fabricacion de 4-(3-trifluorometilfenil)-1,2,3,6-tetrahidropiridinas
AR000813A1 (es) Procedimiento para la obtencion de n-aril y n-heteroarilhidroxilaminas
EA199900304A2 (ru) Замещенные трициклические соединения
ES2051692T3 (es) Procedimiento para preparar 1,2,4-triazol-3-carboxamidas herbicidas.
ES2054626T3 (es) Derivados de 2-azetidinona sustituidos en las posiciones 3,4 y procedimientos para su preparacion.
ES8706148A1 (es) Un procedimiento para preparar nuevos derivados de carbapenem.
BR9509373A (pt) Processo para a preparação de 3- aminobenzonitrilas substituídas
ES2094812T3 (es) Un procedimiento mejorado para la preparacion de derivados sustituidos de indolona.
MX9301079A (es) Metodos de acabado de fibra.
AR006550A1 (es) Metodo de preparacion de inhibidores de fosfodiesterasa iv
PT97032A (pt) Processo para a preparacao de derivado do acido (benzidriloxi-etilpiperidil)-alifatico utilizaveis como agente anti-histaminicos
BR0009453A (pt) Processo para a preparação de um composto
BR9906803A (pt) Processo para tratamento de copd
PT100682A (pt) Agentes anti-helminticos derivados de benzimidazole e processo para a sua preparacao
ES2038693T3 (es) Nuevos acidos aminometanodifosfonicos substituidos.
AR016733A1 (es) Procedimiento de preparacion de 4-(3-piridinil)-1h-imidazol, y los compuestos intermedios empleados